Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Net Income (2016 - 2020)

Historic Net Income for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to -$3.6 million.

  • Larimar Therapeutics' Net Income rose 7254.66% to -$3.6 million in Q1 2020 from the same period last year, while for Dec 2020 it was -$3.6 million, marking a year-over-year increase of 9206.27%. This contributed to the annual value of -$45.4 million for FY2019, which is 2568.26% up from last year.
  • As of Q1 2020, Larimar Therapeutics' Net Income stood at -$3.6 million, which was up 7254.66% from -$7.3 million recorded in Q4 2019.
  • Over the past 5 years, Larimar Therapeutics' Net Income peaked at -$3.6 million during Q1 2020, and registered a low of -$17.8 million during Q1 2016.
  • For the 5-year period, Larimar Therapeutics' Net Income averaged around -$13.0 million, with its median value being -$13.1 million (2019).
  • As far as peak fluctuations go, Larimar Therapeutics' Net Income tumbled by 3275.68% in 2016, and later skyrocketed by 7254.66% in 2020.
  • Larimar Therapeutics' Net Income (Quarter) stood at -$10.3 million in 2016, then decreased by 26.76% to -$13.1 million in 2017, then fell by 10.72% to -$14.5 million in 2018, then surged by 49.65% to -$7.3 million in 2019, then skyrocketed by 50.66% to -$3.6 million in 2020.
  • Its last three reported values are -$3.6 million in Q1 2020, -$7.3 million for Q4 2019, and -$12.9 million during Q3 2019.